{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:46:21Z","timestamp":1786117581127,"version":"build-2736575974"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0647_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Children with differentiated thyroid cancer (DTC) often present with lung metastases but historically have good outcomes. Radioactive iodine (RAI) is commonly used to treat these children. Given the rarity of this condition, little evidence detailing long-term outcomes and risk of radiation pneumonitis exists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0647_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of patients &lt;20 years old who received RAI for DTC lung metastases between 1973 and 2018. Disease-free survival (DFS) was calculated from diagnosis to last follow-up. Overall survival and rates of acute and late radiation pneumonitis were determined by chart review and obituary searches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0647_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixteen patients met eligibility criteria. Fourteen presented with thyroid, nodal, and lung disease; one presented with thyroid and nodal disease with nodal and lung recurrence; and one presented with thyroid-only disease with nodal and lung recurrence. All patients underwent thyroidectomy, 10 underwent neck dissection, and four underwent lymph node excision. Median per-treatment and cumulative RAI dose were 100\u202fmCi (20\u2013270\u202fmCi) and 340\u202fmCi (25\u2013970\u202fmCi), respectively. Median follow-up was 13 years (1\u201332 years). Fifteen patients (88.2\u202f%) were alive at last follow-up. Twelve had no evidence of disease, two had improved but persistent I-131 uptake within lungs and surgical bed, and one had improved but persistent lung metastases alone. No evidence of symptomatic radiation pneumonitis was evident in the medical records of these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0647_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients &lt;20 with DTC lung metastases have high survival following thyroidectomy and RAI treatment and apparently low rates of radiation pneumonitis despite high cumulative doses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0647","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:58:52Z","timestamp":1773763132000},"page":"332-341","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric thyroid cancer lung metastases and RAI: long-term results"],"prefix":"10.1515","volume":"39","author":[{"given":"Ryan C.","family":"Mueller","sequence":"first","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Rammohan","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Apicelli","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Arbelaez","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrokh","family":"Dehdashti","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Siegel","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Prasad","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry W.","family":"Grigsby","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Markovina","sequence":"additional","affiliation":[{"name":"12275 Washington University School of Medicine , St. Louis , MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"2026080613594070856_j_jpem-2025-0647_ref_001","doi-asserted-by":"crossref","unstructured":"Wang, LY, Palmer, FL, Nixon, IJ, Thomas, D, Patel, SG, Shaha, AR, et al.. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. Thyroid 2014;24:1594\u20139. https:\/\/doi.org\/10.1089\/thy.2014.0173.","DOI":"10.1089\/thy.2014.0173"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_002","doi-asserted-by":"crossref","unstructured":"Vassilopoulou-Sellin, R, Klein, MJ, Smith, TH, Samaan, NA, Frankenthaler, RA, Goepfert, H, et al.. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 1993;71:1348\u201352. https:\/\/doi.org\/10.1002\/1097-0142(19930215)71:4<1348::aid-cncr2820710429>3.0.co;2-3.","DOI":"10.1002\/1097-0142(19930215)71:4<1348::AID-CNCR2820710429>3.0.CO;2-3"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_003","doi-asserted-by":"crossref","unstructured":"Grigsby, PW, Gal\u2010or, A, Michalski, JM, Doherty, GM. Childhood and adolescent thyroid carcinoma. Cancer 2002;95:724\u20139. https:\/\/doi.org\/10.1002\/cncr.10725.","DOI":"10.1002\/cncr.10725"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_004","doi-asserted-by":"crossref","unstructured":"Alzahrani, AS, Alswailem, M, Moria, Y, Almutairi, R, Alotaibi, M, Murugan, AK, et al.. Lung metastasis in pediatric thyroid cancer: radiological pattern, molecular genetics, response to therapy, and outcome. J Clin Endocrinol Metab 2019;104:103\u201310. https:\/\/doi.org\/10.1210\/jc.2018-01690.","DOI":"10.1210\/jc.2018-01690"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_005","doi-asserted-by":"crossref","unstructured":"La Quaglia, MP, Black, T, Holcomb, GW, Sklar, C, Azizkhan, RG, Haase, GM, et al.. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. a report from the surgical discipline committee of the children\u2019s cancer group. J Pediatr Surg 2000;35:955\u20139. https:\/\/doi.org\/10.1053\/jpsu.2000.6935.","DOI":"10.1053\/jpsu.2000.6935"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_006","doi-asserted-by":"crossref","unstructured":"Alzahrani, AS, Alkhafaji, D, Tuli, M, Al\u2010Hindi, H, Sadiq, BB. Comparison of differentiated thyroid cancer in children and adolescents (\u226420 years) with young adults. Clin Endocrinol 2016;84:571\u20137. https:\/\/doi.org\/10.1111\/cen.12845.","DOI":"10.1111\/cen.12845"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_007","doi-asserted-by":"crossref","unstructured":"Bal, CS, Garg, A, Chopra, S, Ballal, S, Soundararajan, R. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases. J Pediatr Endocrinol Metab 2015;28. https:\/\/doi.org\/10.1515\/jpem-2014-0247.","DOI":"10.1515\/jpem-2014-0247"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_008","doi-asserted-by":"crossref","unstructured":"Lazar, L, Lebenthal, Y, Steinmetz, A, Yackobovitch-Gavan, M, Phillip, M. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr 2009;154:708\u201314. https:\/\/doi.org\/10.1016\/j.jpeds.2008.11.059.","DOI":"10.1016\/j.jpeds.2008.11.059"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_009","doi-asserted-by":"crossref","unstructured":"Nies, M, Vassilopoulou-Sellin, R, Bassett, RL, Yedururi, S, Zafereo, ME, Cabanillas, ME, et al.. Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape. J Clin Endocrinol Metab 2021;106:1683\u201397. https:\/\/doi.org\/10.1210\/clinem\/dgaa935.","DOI":"10.1210\/clinem\/dgaa935"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_010","doi-asserted-by":"crossref","unstructured":"Markovina, S, Grigsby, PW, Schwarz, JK, DeWees, T, Moley, JF, Siegel, BA, et al.. Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence. Thyroid 2014;24:1121\u20136. https:\/\/doi.org\/10.1089\/thy.2013.0297.","DOI":"10.1089\/thy.2013.0297"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_011","doi-asserted-by":"crossref","unstructured":"Sanders, LE, Cady, B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998;133. https:\/\/doi.org\/10.1001\/archsurg.133.4.419.","DOI":"10.1001\/archsurg.133.4.419"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_012","doi-asserted-by":"crossref","unstructured":"Showalter, TN, Siegel, BA, Moley, JF, Baranski, TJ, Grigsby, PW. Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother Radiopharm 2008;23:655\u201360. https:\/\/doi.org\/10.1089\/cbr.2008.0501.","DOI":"10.1089\/cbr.2008.0501"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_013","doi-asserted-by":"crossref","unstructured":"Ganly, I, Nixon, IJ, Wang, LY, Palmer, FL, Migliacci, JC, Aniss, A, et al.. Survival from differentiated thyroid cancer: what has age got to Do with it? Thyroid 2015;25:1106\u201314. https:\/\/doi.org\/10.1089\/thy.2015.0104.","DOI":"10.1089\/thy.2015.0104"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_014","unstructured":"After radioactive iodine treatment for thyroid cancer. https:\/\/www.cancerresearchuk.org\/about-cancer\/thyroid-cancer\/treatment\/radiotherapy\/radioactive-iodine-treatment\/after-radioactive-iodine-treatment [Accessed 18 Oct 2025]."},{"key":"2026080613594070856_j_jpem-2025-0647_ref_015","unstructured":"Sgouros, G, Song, H, Ladenson, PW, Wahl, RL. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule. J Nucl Med 2006;47:1977\u201384."},{"key":"2026080613594070856_j_jpem-2025-0647_ref_016","unstructured":"Song, H, He, B, Prideaux, A, Du, Y, Frey, E, Kasecamp, W, et al.. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases. J Nucl Med 2006;47:1985\u201394."},{"key":"2026080613594070856_j_jpem-2025-0647_ref_017","doi-asserted-by":"crossref","unstructured":"Chen, L, Shen, Y, Luo, Q, Yu, Y, Lu, H, Zhu, R. Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma. Thyroid 2010;20:337\u201340. https:\/\/doi.org\/10.1089\/thy.2009.0266.","DOI":"10.1089\/thy.2009.0266"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_018","doi-asserted-by":"crossref","unstructured":"Halada, S, Leftin Dobkin, S, Baran, JA, Sisko, L, Robbins, SL, Rapp, JB, et al.. Pulmonary injury after radioactive iodine therapy in pediatric papillary thyroid cancer: a case report. Horm Res Paediatr 2024;97:477\u201382. https:\/\/doi.org\/10.1159\/000534190.","DOI":"10.1159\/000534190"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_019","doi-asserted-by":"crossref","unstructured":"Ball, JE, Alpers, JB, Lewallen, CG, Sonenberg, M, Berman, M, Rawson, RW. Radiation pneumonitis and fibrosis: a complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid. J Clin Endocrinol Metab 1957;17:1263\u201376. https:\/\/doi.org\/10.1210\/jcem-17-11-1263.","DOI":"10.1210\/jcem-17-11-1263"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_020","doi-asserted-by":"crossref","unstructured":"Reiners, C, Biko, J, Haenscheid, H, Hebestreit, H, Kirinjuk, S, Baranowski, O, et al.. Twenty-five years after chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma. J Clinl Endocrinol Metab 2013;98:3039\u201348. https:\/\/doi.org\/10.1210\/jc.2013-1059.","DOI":"10.1210\/jc.2013-1059"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_021","doi-asserted-by":"crossref","unstructured":"Haugen, BR, Alexander, EK, Bible, KC, Doherty, GM, Mandel, SJ, Nikiforov, YE, et al.. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2015;26:1\u2013133.","DOI":"10.1089\/thy.2015.0020"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_022","doi-asserted-by":"crossref","unstructured":"Vaccarella, S, Lortet-Tieulent, J, Colombet, M, Davies, L, Stiller, CA, Sch\u00fcz, J, et al.. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol 2021;9:144\u201352. https:\/\/doi.org\/10.1016\/s2213-8587(20)30401-0.","DOI":"10.1016\/S2213-8587(20)30401-0"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_023","doi-asserted-by":"crossref","unstructured":"Davies, L, Welch, HG. Increasing incidence of thyroid cancer in the United States, 1973\u20132002. JAMA 2006;295:2164. https:\/\/doi.org\/10.1001\/jama.295.18.2164.","DOI":"10.1001\/jama.295.18.2164"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_024","doi-asserted-by":"crossref","unstructured":"Zhang, B, Wu, W, Shang, X, Huang, D, Liu, M, Zong, L. Incidence and prognosis of thyroid cancer in children: based on the SEER database. Pediatr Surg Int 2022;38:445\u201356. https:\/\/doi.org\/10.1007\/s00383-022-05069-3.","DOI":"10.1007\/s00383-022-05069-3"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_025","doi-asserted-by":"crossref","unstructured":"Bernier, M, Withrow, DR, Berrington De Gonzalez, A, Lam, CJK, Linet, MS, Kitahara, CM, et al.. Trends in pediatric thyroid cancer incidence in the United States, 1998\u20132013. Cancer 2019;125:2497\u2013505. https:\/\/doi.org\/10.1002\/cncr.32125.","DOI":"10.1002\/cncr.32125"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_026","unstructured":"SEER. SEER cancer statistics review, 1975\u20132018. https:\/\/seer.cancer.gov\/csr\/1975_2018\/index.html [Accessed 20 Nov 2024]."},{"key":"2026080613594070856_j_jpem-2025-0647_ref_027","doi-asserted-by":"crossref","unstructured":"Paulson, VA, Rudzinski, ER, Hawkins, DS. Thyroid cancer in the pediatric population. Genes [Internet] 2019;10:723. https:\/\/doi.org\/10.3390\/genes10090723.","DOI":"10.3390\/genes10090723"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_028","doi-asserted-by":"crossref","unstructured":"Chrisoulidou, A, Boudina, M, Tzemailas, A, Doumala, E, Iliadou, PK, Patakiouta, F, et al.. Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer. Thyroid Res 2011;4:12. https:\/\/doi.org\/10.1186\/1756-6614-4-12.","DOI":"10.1186\/1756-6614-4-12"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_029","doi-asserted-by":"crossref","unstructured":"Kowalski, LP, Filho, JG, Pinto, CAL, Carvalho, AL, De Camargo, B. Long-term survival rates in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:746. https:\/\/doi.org\/10.1001\/archotol.129.7.746.","DOI":"10.1001\/archotol.129.7.746"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_030","doi-asserted-by":"crossref","unstructured":"Kuhlen, M, Kunstreich, M, Eilsberger, F, Luster, M, Redlich, A. Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis. Eur Thyroid J 2025;14:e240341. https:\/\/doi.org\/10.1530\/etj-24-0341.","DOI":"10.1530\/ETJ-24-0341"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_031","doi-asserted-by":"crossref","unstructured":"Pawelczak, M, David, R, Franklin, B, Kessler, M, Lam, L, Shah, B. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following 131I treatment: a systematic review. Thyroid 2010;20:1095\u2013101. https:\/\/doi.org\/10.1089\/thy.2009.0446.","DOI":"10.1089\/thy.2009.0446"},{"key":"2026080613594070856_j_jpem-2025-0647_ref_032","doi-asserted-by":"crossref","unstructured":"Pasqual, E, Schonfeld, S, Morton, LM, Villoing, D, Lee, C, Berrington De Gonzalez, A, et al.. Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J Clin Orthod 2022;40:1439\u201349. https:\/\/doi.org\/10.1200\/jco.21.01841.","DOI":"10.1200\/JCO.21.01841"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0647\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0647\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:02:09Z","timestamp":1786024929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0647\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,17]]},"published-print":{"date-parts":[[2026,4,24]]}},"alternative-id":["10.1515\/jpem-2025-0647"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0647","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}